Cure My Disease

Don't miss your cure!

 Log in / Sign up

Prostate cancer disparities: uncovering the hidden drivers

NCT ID NCT07690579

Recruiting now Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study investigates why Black men are more likely to be diagnosed with and die from prostate cancer compared to White men. Researchers will survey 350 men who are scheduled for prostate removal surgery and review their medical records. The goal is to identify social, structural, lifestyle, and genetic factors that contribute to these disparities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could identify key factors driving prostate cancer disparities and point toward ways to reduce them.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear causes, and results may not lead to direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hormone-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATE CANCER RECURRENT PROSTATE METASTASES

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.